Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Vascular Function in Prediabetes
NCT06526494Phase 2Withdrawn
- Start
- Nov 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in prediabetes. Planned start Nov 2024; status: withdrawn.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT06526494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06526494.